| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 56.40B | 61.03B | 57.41B | 53.40B | 44.85B | 45.93B |
| Gross Profit | 10.36B | 11.58B | 10.37B | 8.88B | 7.03B | 6.94B |
| EBITDA | 5.69B | 6.36B | 5.96B | 4.65B | 3.37B | 4.22B |
| Net Income | 3.11B | 3.87B | 3.19B | 2.21B | 1.63B | 2.25B |
Balance Sheet | ||||||
| Total Assets | 56.21B | 61.99B | 60.71B | 62.75B | 54.80B | 55.59B |
| Cash, Cash Equivalents and Short-Term Investments | 22.61B | 20.02B | 23.35B | 19.50B | 20.65B | 21.57B |
| Total Debt | 111.00M | 319.00M | 330.00M | 371.00M | 14.00M | 28.00M |
| Total Liabilities | 12.68B | 15.90B | 16.81B | 20.88B | 14.08B | 15.73B |
| Stockholders Equity | 43.53B | 46.09B | 43.89B | 41.87B | 40.72B | 39.86B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 29.00M | 7.19B | 1.47B | 1.85B | -1.57B |
| Operating Cash Flow | 0.00 | 554.00M | 7.60B | 2.25B | 3.31B | 199.00M |
| Investing Cash Flow | 0.00 | -3.30B | -3.42B | -1.44B | -2.94B | -3.04B |
| Financing Cash Flow | 0.00 | -2.12B | -1.39B | -1.29B | -900.00M | -943.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥276.09B | 9.89 | 7.43% | 2.78% | 2.69% | -6.90% | |
78 Outperform | ¥1.50T | 17.13 | 14.94% | 2.00% | 10.44% | 50.36% | |
78 Outperform | ¥699.04B | 11.33 | ― | 2.15% | 0.46% | 38.67% | |
77 Outperform | ¥49.43B | 6.36 | 7.09% | 3.06% | 9.75% | 22.98% | |
77 Outperform | ¥101.57B | 6.30 | ― | 4.38% | -6.07% | 44.83% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |